Dr Reddy’s Launches Low-Cost Semaglutide Generic ‘Obeda’ in India’s Booming GLP-1 Market
Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…
Central Drugs Standard Control Organisation
Read More
FTA Hopes Fail to Halt Big Pharma Pullback from India
Novartis AG’s move to exit its small Indian subsidiary once again highlights the limited appetite of global pharmaceutical giants to…
NIMS Hyderabad Inaugurates Stem Cell Centre of Excellence to Expand Access to Regenerative Therapies
India is facing a rising incidence of metabolic, degenerative and autoimmune disorders, largely due to changing lifestyles and increasing environmental…
Counterfeit Abhayrab Vaccine Triggers Global Alerts, Exposes Gaps in India’s Drug Recall System
The detection of a counterfeit batch of Abhayrab, a rabies vaccine manufactured by government-owned Indian Immunologicals Limited (IIL), has highlighted…
AIIMS Delhi Conducts India’s First Clinical Trial of Advanced Brain Stent
AIIMS Delhi has conducted India’s first dedicated clinical trial of an advanced brain stent for the treatment of severe strokes,…
CDSCO Launches 100-day Awareness Drive on GST Reduction in MedTech Sector
The Central Drugs Standard Control Organisation (CDSCO) has initiated a 100-day nationwide awareness campaign highlighting the recent reduction in Goods…
WHO Monitoring Cough Syrup Case; Seeks Clarification on Exports
The World Health Organisation said it is closely monitoring the situation in India following the deaths of 20 children in…
Coldrif Cough Syrup Linked to Child Deaths; UP Orders Ban
The Uttar Pradesh government on Sunday (Oct 5) banned the sale, import, and export of Coldrif cough syrup following reports…
Andhra Pradesh Gets Its First CDSCO-Approved Medical Device Audit Body
In a key development for the medical device industry, Andhra Pradesh now has its first Central Drugs Standard Control Organisation…
Health Ministry Plans to Suspend Licenses for Substandard Drugs: Report
The Union Health Ministry is reportedly considering new regulations that would allow for the immediate suspension of product licenses for…